207_Combined course Presentations

First page Table of contents Previous page 792 Next page Last page

ACT II CR at 26 weeks

MMC

CisP

Difference (95% CI) +0.9% (-4.9 to 3.1)

P value

90.5% (391/432)

89.6% (386/431)

p =0.64

Progressive disease

5.1% (22/432)

3.5% (13/431)

Made with